G-CON Manufacturing Revenue and Competitors
Estimated Revenue & Valuation
- G-CON Manufacturing's estimated annual revenue is currently $17.1M per year.
- G-CON Manufacturing's estimated revenue per employee is $155,000
Employee Data
- G-CON Manufacturing has 110 Employees.
- G-CON Manufacturing grew their employee count by -21% last year.
G-CON Manufacturing's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Executive Director Business Development | Reveal Email/Phone |
3 | VP Innovations | Reveal Email/Phone |
4 | SVP, General Manager G-CON PODs | Reveal Email/Phone |
5 | Director Finance And Accounting | Reveal Email/Phone |
6 | GCBS Director BD & Sales | Reveal Email/Phone |
7 | Director Operations | Reveal Email/Phone |
8 | Director, Business Development | Reveal Email/Phone |
9 | Director Marketing | Reveal Email/Phone |
10 | Director Automation | Reveal Email/Phone |
G-CON Manufacturing Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is G-CON Manufacturing?
G-CON Manufacturing, Inc.'s prefabricated, turnkey cleanroom systems represent a significant transition to forward thinking in pharmaceutical and biopharmaceutical processing. G-CON Manufacturing, the innovator of autonomous cleanroom PODs, turned the challenges experienced by the biopharmaceutical industry into readily deployable, flexible, mobile and scalable cleanroom solutions. PODs are ideal for multi-product sites, rigorous containment needs, and on demand scaling of production and laboratory space. Building on its first design in 2009, G-CON now has a wide array of cleanroom PODs in their product portfolio to accommodate the increased demand from the pharmaceutical, biopharmaceutical and cell therapeutic industries. Moreover, G-CON's patent portfolio continues to grow which will effectively preclude imitators from copying G-CON's initial and more recent innovations. At G-CON, we will continue to evolve and grow with the industry to provide a comprehensive cleanroom solution that truly is flexible, scalable and fast, all for a fair and known price from the time the contract is signed.
keywords:Biotechnology,Cleantech,Hardware,Hardware Peripherals,Healthcare,Pharmaceuticals,Solar Power,Wind PowerN/A
Total Funding
110
Number of Employees
$17.1M
Revenue (est)
-21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
G-CON Manufacturing News
G-CON Manufacturing Inc. has acquired Plasteurop, a France-based manufacturer of critical cleanroom components.
G-CON Honored with the Europe Bioprocessing Excellence Award 2021 We are very proud and recognize this award as a sign of the continued validation of G-CON’s efforts within the industry. COLLEGE STATION, Texas (PRWEB) October 28, 2021 IMAPAC, the organizing committee of the Europe Bioprocessin ...
Jody Lynn DeStefanis, General Counsel Jody brings a wealth of knowledge and experience in several areas critical to our continued growth... COLLEGE STATION, Texas (PRWEB) August 12, 2021 G-CON Manufacturing, the market leader in off-site prefabricated, flexible cleanroom solutions, announced t ...
Through its acquisition of G-CON, Summa Equity enters the rapidly growing biopharmaceutical manufacturing market, including cell and gene therapy manufacturing. STOCKHOLM, July 20, 2021 /PRNewswire/ -- Summa Equity Fund II ("Summa") has acquired a majority stake in G-CON, a leading US-based m ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $26.4M | 129 | 4% | N/A |
#2 | $31.6M | 129 | 8% | N/A |
#3 | $19.8M | 132 | 17% | N/A |
#4 | $16.7M | 134 | -1% | N/A |
#5 | $20.3M | 135 | N/A | N/A |